Akash Sureka
Akash Sureka invests in companies and founders addressing large market opportunities with strong teams, differentiation, and product. He is particularly interested in areas like Fintech, Edtech, Healthtech, Sales Tech, Mar Tech, Revenue and Supply Management Tech, and Travel Tech.
About Akash Sureka
Akash Sureka is a Pune-based solo angel investor who writes pre-seed and seed checks, with a stated focus on digital health and a public check-size range below two hundred and fifty thousand dollars, which positions him as a small-check, early-conviction angel rather than a lead investor. The data here is thin beyond those signals: no website, no Twitter, no Crunchbase, no published thesis statement, and the LinkedIn profile is the only public surface; founders evaluating Akash should treat the signals as a starting point and verify deal cadence, current capital position, and area of focus directly through outreach or through a warm reference. The geography signal is meaningful: a Pune-based angel will typically have the strongest network in the Indian early-stage ecosystem (Pune, Mumbai, Bangalore, Delhi-NCR) and is most useful for Indian founders or for cross-border founders with India operations or India-based engineering teams. The digital health focus is consistent with a meaningful slice of recent Indian angel activity, and a solo angel who has chosen digital health as a focus area is likely to have either domain experience (clinician, healthcare operator, or healthcare-services founder) or a thesis built through prior deals, and either way is more likely to engage with a digital-health-specific pitch than with a generalist healthcare deck. Founders who should consider approaching Akash are Indian pre-seed and seed-stage digital health founders looking to fill out a small angel round with domain-aware checks, particularly founders building consumer health, virtual care, healthcare workflow software, or digital therapeutics for the Indian market or for global markets from India. Founders should not approach Akash for institutional-sized leads, for capital-intensive categories like devices or biotech, for stages beyond seed, or for non-digital-health businesses, since the public profile and check size do not match those use cases. The entry path is direct LinkedIn outreach with a tight, specific pitch in clear terms about the company, the wedge, the round, and the specific reason you want this angel on your cap table; warm intros through the Indian startup ecosystem (accelerators, founder networks, ecosystem events, other angels) materially improve response rates. When you reach out, lead with the digital health insight and the team’s domain experience, and be honest about the India unit-economics realities (lower ARPU, longer payback periods, fragmented payer environment) that any Indian healthcare angel will already understand. Caveats: with limited public data and a small check size, founders should calibrate expectations: the value of a solo angel like Akash is the warm signal, the network introductions, and the domain-aware advice rather than the dollar amount; founders should verify current activity through reference calls before sending detailed materials, since a small-check angel who has been quiet for twelve months is a very different proposition from one actively writing checks each quarter.
Founder reviews
Other portfolio companies
Companies in Akash Sureka's portfolio not currently in our directory.
- Nushala · 2021
- Zoop
- Hoopz
Team
Pitch / review this investor
Have you raised from Akash Sureka? Founders only — share your honest experience (anonymous OK, moderated before publishing).